Our Brands
Over 2,000,000 scientist hours into new peptide drug development, ISSAR has touched 100000 plus lives
Development Pipeline
Solving the unmet healthcare needs using novel peptide technology
Novoskin®
Vitiligo - Topical
Xylentra®
Wound care - Topical
IS -107
Solid tumors - Injectable
IS - 217
Soriacare®
Psoriasis - Injectable
Topical
ISSAR'S Pre-Clinical
Pipeline
INDIA
INDIA
US FDA
INDIA
US FDA
IBD (Injectable)
Sepsis (Injectable)
Rheumatoid Arthritis
Atopic Dermatitis